Beta cell function in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2 year double-blind randomised controlled study

被引：0
|
作者：
Johansen, O. [1 ]
Boehm, B. [2 ]
Grill, V. [3 ]
Torjesen, P. A. [4 ]
Bhattacharya, S. [5 ]
Patel, S. [6 ]
Wetzel, K. [5 ]
Woerle, H. -J. [7 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Asker, Norway
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway
[4] Aker Univ Hosp, Oslo, Norway
[5] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[6] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[7] Boehringer Ingelheim KG, Ingelheim, Germany
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
148
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [31] Effect of Teneligliptin versus Glimepiride on Tumour Necrosis Factor Alpha and High Sensitivity C-Reactive Protein in Type 2 Diabetes Mellitus Patients Treated with Metformin: A Randomised Double-blind Parallel Group Study
    Butul, Maleha
    Usharani, Pingali
    Subbalaxmi, M. V. S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (11) : FC01 - FC06
  • [32] DEPRESSION DURING TREATMENT WITH BETA-BLOCKERS - RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    SORGI, P
    RATEY, J
    KNOEDLER, D
    ARNOLD, W
    COLE, L
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1992, 4 (02) : 187 - 189
  • [33] Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Gomis, R.
    Espadero, R. -M.
    Jones, R.
    Woerle, H. J.
    Dugi, K. A.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 653 - 661
  • [34] Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Woerle, H. -J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 65 - 74
  • [35] Training of attentional control in mild cognitive impairment with executive deficits: Results from a double-blind randomised controlled study
    Gagnon, Lyssa G.
    Belleville, Sylvie
    NEUROPSYCHOLOGICAL REHABILITATION, 2012, 22 (06) : 809 - 835
  • [36] Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes A ≥ 52-week randomized, double-blind study
    Yki-Jarvinen, Hannele
    Rosenstock, Julio
    Duran-Garcia, Santiago
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Thiemann, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES CARE, 2013, 36 (12) : 3875 - 3881
  • [37] Acute effects of mango leaf extract on cognitive function in healthy adults: a randomised, double-blind, placebo-controlled crossover study
    Dodd, Fiona L.
    Kennedy, David O.
    Johnson, Jodee
    Haworth, Emily
    Greener, Jessica P.
    Jackson, Philippa A.
    FRONTIERS IN NUTRITION, 2024, 11
  • [38] Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial
    Muskiet, Marcel H. A.
    Tonneijck, Lennart
    Smits, Mark M.
    Kramer, Mark H. H.
    Ouwens, D. Margriet
    Hartmann, Bolette
    Holst, Jens J.
    Touw, Daan J.
    Danser, A. H. Jan
    Joles, Jaap A.
    van Raalte, Daniel H.
    DIABETES CARE, 2020, 43 (11) : 2889 - 2893
  • [39] Effects of vitamin D supplementation on cognitive function in healthy, community dwelling older adults: Results from a randomised double-blind placebo-controlled pilot trial
    Aspell, N.
    Healy, M.
    Mc Partlin, J.
    Lawlor, B. A.
    O'Sullivan, M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2017, 76 (OCE3) : E59 - E59
  • [40] Adding glimepiride to insulin plus metformin in type 2 diabetes of more than 10 years' duration-A randomised, double-blind, placebo-controlled, cross-over study
    Nyback-Nakell, A.
    Adamson, U.
    Lins, P. E.
    Landstedt-Hallin, L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 286 - 291
12345